Terént, Andreas

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

Sandset, E. C., Bath, P. M., Boysen, G., Jatuzis, D., Kõrv, J., Lüders, S., Murray, G. D., Richter, P. S., Roine, R. O., Terént, A., et al. (2011) · The Lancet

Acute Ischemic Stroke ManagementBlood Pressure and Hypertension Studies

Cited by 541

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1

Friberg, L., Skeppholm, M., & Terént, A. (2015) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 207

Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke

Henriksson, K. M., Farahmand, B., Åsberg, S., Edvardsson, N., & Terént, A. (2012) · International Journal of Stroke

Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research

Cited by 76

Epidemiological Perspective of Body Position and Arm Level in Blood Pressure Measurement

Terént, A., & Breig-åsberg, E. (1994) · Blood Pressure

Blood Pressure and Hypertension StudiesNon-Invasive Vital Sign Monitoring

Cited by 70

Age relations of cardiovascular risk factors in a traditional Melanesian society: the Kitava Study

Lindeberg, S., Berntorp, E., Nilsson-Ehle, P., Terént, A., & Vessby, B. (1997) · The American Journal of Clinical Nutrition

Indigenous Health and EducationCardiovascular Health and Risk Factors

Cited by 56

Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial

Åsberg, S., Hijazi, Z., Norrving, B., Terént, A., Öhagen, P., & Oldgren, J. (2017) · Trials

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 43